OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways
Jiaxin Liu, Yicheng Cheng, Ming Zheng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

E3 ubiquitin ligases: styles, structures and functions
Quan Yang, Jinyao Zhao, Dan Chen, et al.
Molecular Biomedicine (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 220

The RING finger protein family in health and disease
Chunmei Cai, Yan‐Dong Tang, Jingbo Zhai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 104

Epigenetic modification of m6A regulator proteins in cancer
Yumin Wang, Yan Wang, Harsh Patel, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 83

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 77

Fasting: From Physiology to Pathology
Dongmei Tang, Qiuyan Tang, Wei Huang, et al.
Advanced Science (2023) Vol. 10, Iss. 9
Open Access | Times Cited: 39

Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity
Ziyi Fu, Siqi Chen, Yueming Zhu, et al.
Science Advances (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 23

Unleashing the power of immune checkpoints: Post-translational modification of novel molecules and clinical applications
Jie Wang, Yian Wang, Xianjie Jiang, et al.
Cancer Letters (2024) Vol. 588, pp. 216758-216758
Closed Access | Times Cited: 14

FBW7-mediated ubiquitination and destruction of PD-1 protein primes sensitivity to anti-PD-1 immunotherapy in non-small cell lung cancer
Jiaxin Liu, Lingyun Wei, Nan Hu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e005116-e005116
Open Access | Times Cited: 37

Sirtuin1-p53: A potential axis for cancer therapy
Jiayi Yin, Xin-tong Lu, Meng-Ling Hou, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115543-115543
Closed Access | Times Cited: 18

E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities
Qiang Zou, Meng Liu, Kewei Liu, et al.
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 545-570
Open Access | Times Cited: 17

Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer
MyongHak Ri, Juan Ma, Xuejun Jin
Journal of Ethnopharmacology (2021) Vol. 281, pp. 114370-114370
Closed Access | Times Cited: 35

Regulation of Ferroptosis Pathway by Ubiquitination
Xinbo Wang, Yanjin Wang, Zan Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 33

Roles of ubiquitin-specific proteases in inflammatory diseases
Rui Chen, Hui Zhang, Linke Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Targeting Epigenetic and Post-translational Modifications Regulating Pyroptosis for the Treatment of Inflammatory Diseases
Ri-Wen, Yuhang Yang, Tie‐Ning Zhang, et al.
Pharmacological Research (2024) Vol. 203, pp. 107182-107182
Open Access | Times Cited: 5

Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges
Peng Ye, Xiaoxia Chi, Jong‐Ho Cha, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3309-3309
Open Access | Times Cited: 30

TRIM14 inhibits OPTN-mediated autophagic degradation of KDM4D to epigenetically regulate inflammation
Di Liu, Zhiyao Zhao, Yuanchu She, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 7
Open Access | Times Cited: 22

Elucidating the role of ubiquitination and deubiquitination in osteoarthritis progression
Chenxiao Zheng, Jiayi Chen, Yurui Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12

RNF20 dual regulation of MDA5 signaling to maintain immune homeostasis in chickens
Jie Wang, Qiuju Liu, Kehui Zhang, et al.
Journal of Virology (2025)
Open Access

USP19 deficiency enhances T-cell-mediated antitumor immunity by promoting PD-L1 degradation in colorectal cancer
Feng Shi, Li Gui, Yi Liu, et al.
Pharmacological Research (2025) Vol. 214, pp. 107668-107668
Open Access

TPI1 promotes p53 ubiquitination in bladder cancer by recruiting AKT to enhance MDM2 phosphorylation
Chenyang Wang, Shun Wan, Kunpeng Li, et al.
Pharmacological Research (2025) Vol. 215, pp. 107695-107695
Open Access

USP18 Confers Paclitaxel Resistance in Non‐Small Cell Lung Cancer by Stabilizing SHANK1 Expression Via Deubiquitination
Lixun Chai, Yanlong Sun, Yunfei Wang, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access

UBA protein family: An emerging set of E1 ubiquitin ligases in cancer—A review
Huhu Zhang, Fulin Sun, Hongyu Cao, et al.
International Journal of Biological Macromolecules (2025), pp. 142277-142277
Closed Access

Page 1 - Next Page

Scroll to top